Benefit/ risk- forholdet for systemisk behandling med kombinationen af loratadin og pseudoephedrin versus behandling med loratadin og en topisk anvendelse af pseudoephedrin blev drøftet.
The benefit/ risk of the systemic treatment with the combination of loratadine and pseudoephedrine versus treatment with loratadine and a topical application of pseudoephedrine was discussed.